Josh Mandel-Brehm, Chief Executive Officer at Camp4 Therapeutics, bought CAMP on Aug 3, 2026
Data as of Oct 16
▲ BUY$10.8K6,551 shares at $1.65Josh Mandel-Brehm Chief Executive OfficerCAMP Camp4 Therapeutics Corp
- Traded
- Aug 3, 2026
- Disclosed
- Aug 5, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CAMP since disclosure
−20.9%
Similar stocks (XLV) since disclosure
+7.6%
XLV — its sector index fund
Change in closing price from Aug 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.